EVERSANA Selected by Innovacell as Commercialization Partner to Advance Novel Cell Therapy ICEF15 in the United States
CHICAGO, July 30, 2026 /PRNewswire/ -- EVERSANA®, a leading provider of global commercialization services to the life sciences industry, today announced it has been selected by Tokyo-based biotechnology company Innovacell Inc. as its exclusive commercialization partner in the United...
CHICAGO, July 30, 2026 /PRNewswire/ -- EVERSANA®, a leading provider of global commercialization services to the life sciences industry, today announced it has been selected by Tokyo-based biotechnology company Innovacell Inc. as its exclusive commercialization partner in the United...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.